# Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection

> **NCT04507607** · EARLY_PHASE1 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Hepatitis B
- Mother-to-child Block
- Antiviral Treatment

## Interventions

- **DRUG:** Tenofovir Alafenamide 25 MG

## Key facts

- **NCT ID:** NCT04507607
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04507607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04507607, "Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04507607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*